As of 2025-03-19, the Relative Valuation of Bioventus Inc (BVS) is (6.69) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.56 USD, the upside of Bioventus Inc based on Relative Valuation is -170.0%.
The range of the Relative Valuation is (5.72) - (9.55) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.2x - 23.1x | 12.8x |
| Forward P/E multiples | 11.8x - 19.6x | 14.7x |
| Fair Price | (5.72) - (9.55) | (6.69) |
| Upside | -159.8% - -199.9% | -170.0% |
| Date | P/E |
| 2025-03-18 | -19.65 |
| 2025-03-17 | -20.14 |
| 2025-03-14 | -19.75 |
| 2025-03-13 | -19.75 |
| 2025-03-12 | -20.70 |
| 2025-03-11 | -22.20 |
| 2025-03-10 | -18.01 |
| 2025-03-07 | -18.91 |
| 2025-03-06 | -19.44 |
| 2025-03-05 | -20.94 |
| 2025-03-04 | -20.74 |
| 2025-03-03 | -20.86 |
| 2025-02-28 | -20.84 |
| 2025-02-27 | -20.00 |
| 2025-02-26 | -21.07 |
| 2025-02-25 | -20.82 |
| 2025-02-24 | -20.62 |
| 2025-02-21 | -20.57 |
| 2025-02-20 | -20.45 |
| 2025-02-19 | -21.21 |
| 2025-02-18 | -21.36 |
| 2025-02-14 | -21.40 |
| 2025-02-13 | -21.42 |
| 2025-02-12 | -21.11 |
| 2025-02-11 | -21.95 |
| 2025-02-10 | -22.01 |
| 2025-02-07 | -21.66 |
| 2025-02-06 | -22.28 |
| 2025-02-05 | -22.71 |
| 2025-02-04 | -22.59 |
| 2025-02-03 | -21.58 |
| 2025-01-31 | -21.95 |
| 2025-01-30 | -21.89 |
| 2025-01-29 | -21.56 |
| 2025-01-28 | -21.42 |
| 2025-01-27 | -20.68 |
| 2025-01-24 | -20.62 |
| 2025-01-23 | -20.49 |
| 2025-01-22 | -20.74 |
| 2025-01-21 | -21.03 |
| 2025-01-17 | -20.64 |
| 2025-01-16 | -20.78 |
| 2025-01-15 | -19.96 |
| 2025-01-14 | -18.23 |
| 2025-01-13 | -18.83 |
| 2025-01-10 | -19.07 |
| 2025-01-08 | -19.69 |
| 2025-01-07 | -19.63 |
| 2025-01-06 | -20.20 |
| 2025-01-03 | -21.46 |